Optimal Supportive Care With Selinexor Improves Outcomes in Patients With Relapsed/Refractory Multiple Myeloma

Treatment Strategies Considering Micro-Environment and Clonal Evolution in Multiple Myeloma

(2021) Kazuhito Suzuki et al.   Cancers

Models of Palliative Care Delivery for Patients With Cancer

(2020) David Hui et al.   JOURNAL OF CLINICAL ONCOLOGY

Supportive care in cancer—a MASCC perspective

(2020) Ian Olver et al.   SUPPORTIVE CARE IN CANCER

The pharmacologic management of multiple myeloma in older adults

(2019) Jessica L. Dempsey et al.   EXPERT OPINION ON PHARMACOTHERAPY

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

(2019) Joseph Mikhael et al.   JOURNAL OF CLINICAL ONCOLOGY

Selinexor: First Global Approval

(2019) Yahiya Y. Syed   DRUGS

Oral Selinexor–Dexamethasone for Triple-Class Refractory Multiple Myeloma

(2019) Ajai Chari et al.   NEW ENGLAND JOURNAL OF MEDICINE

Utilization of novel systemic therapies for multiple myeloma: A retrospective study of front‐line regimens using the SEER‐Medicare data

(2019) Daisuke Goto et al.   Cancer Medicine

Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma

(2018) Dan T. Vogl et al.   JOURNAL OF CLINICAL ONCOLOGY

Selinexor plus low-dose bortezomib and dexamethasone for patients with relapsed or refractory multiple myeloma

(2018) Nizar J. Bahlis et al.   BLOOD

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

(2017) S K Kumar et al.   LEUKEMIA

First-in-Class, First-in-Human Phase I Study of Selinexor, a Selective Inhibitor of Nuclear Export, in Patients With Advanced Solid Tumors

(2016) Albiruni R. Abdul Razak et al.   JOURNAL OF CLINICAL ONCOLOGY

Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma

(2016) Mrinal M. Gounder et al.   JOURNAL OF CLINICAL ONCOLOGY

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

(2016) Shaji Kumar et al.   LANCET ONCOLOGY

Outcome of patients with multiple myeloma and hypotension during high-dose chemotherapy

(2015) Noa Biran et al.   AMERICAN JOURNAL OF HEMATOLOGY

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma

(2014) S Vincent Rajkumar et al.   LANCET ONCOLOGY

Consensus recommendations for the uniform reporting of clinical trials: report of the International Myeloma Workshop Consensus Panel 1

(2011) S. V. Rajkumar et al.   BLOOD

Early Palliative Care for Patients with Metastatic Non–Small-Cell Lung Cancer

(2010) Jennifer S. Temel et al.   NEW ENGLAND JOURNAL OF MEDICINE